Latest filing published 24 Jul 2023 for BIOLIDICS LIMITED, €631k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Clearbridge BSA Pte. Ltd.: trading record in brief
Clearbridge BSA Pte. Ltd. discloses dealings in Biolidics Limited to SGX. In total, 5 filings cover trades dated from 28 May 2021 to 21 July 2023.
Both buying and selling appear: 1 purchase, against 3 sales worth €695k. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2023 to date brings 1 purchase and 1 sale.
On 24 July 2023 came the latest disclosure, an open-market sale for €631k in Biolidics Limited. The clock since the last published purchase (22 March 2023) now reads 1,327 days. Between a trade and the moment it shows up on SGX, the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SGX. Past trades are no guide to future returns.
Companies and markets linked to Clearbridge BSA Pte. Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 57,123,300 shares@ SGD 0.016390.8% of flowShareSGX-STISIN SGXE89830751SGX:DD42U6RGIZPODFLR
- 37,500,000 sharesShareSGX-STISIN SGXE89830751SGX:ROC8OA3530AJZDI5Canonical exit: 18 Jun 2023 (T+90)
- ShareSGX-STISIN SGXE89830751SGX:B205LGPJLPP8OJZC
- 2,000,000 shares@ SGD 0.0459.2% of flowShareSGX-STISIN SGXE89830751SGX:WP5ZX0BG71BZ29BQ
- 25,880,800 sharesShareSGX-STISIN SGXE89830751SGX:SL7XGTHZQ0XN556F
5 of 5 declarations